Evidence map›Paper›PMID 40629618›Full record

ArticleMedicine2025

A rare presentation of Wilson disease with normal levels of serum ceruloplasmin and copper and MODY: A case report.

Meihong Han, Zhen Yang

Abstract readCase Reports
In one paragraph

Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Meihong HanDepartment of Infectious Diseases, Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong.ORCID 0000-0002-9834-0956

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleWilson disease (WD) is an autosomal recessive disorder in which mutations in ATP7B lead to excessive copper deposition in the liver, brain, eyes, kidneys, and other organs. Patients with WD can present with hepatic dysfunction, neurological symptoms, rare hemolytic anemia, and renal tubular acidosis. PATIENT CONCERNS: A 27-year-old female patient with liver cirrhosis and maturity-onset diabetes of the young was found to have normal serum ceruloplasmin (25.9, 20-60 mg/dL) and copper levels (17.81, 12.6-23.6 μmol/L). DIAGNOSES: Liver biopsy revealed severe lobular hepatitis (multiple lobular/large necroses), early cirrhosis with a small amount of copper deposits, hepatocyte lipidosis, balloon-like changes, Mallory bodies, and glycogenated hepatocyte nuclei. Genetic analysis of ATP7B exon found 2 variants (c.2333G>T, p. Arg778Leu) in exon 8 and (c.3209C>G, p. Pro1070Arg) in exon 14. Based on the available results, the Leipzig score was 7 and the diagnosis of WD can be confirmed. A late Kayser-Fleischer corneal rings test came back positive.

interventionsThe patient's clinical management included d-penicillamine and insulin. OUTCOMES: At approximately 6 months of follow-up, the patient's liver function was well controlled and the cirrhosis did not progress or have decompensated events. LESSONS: Although WD is treatable, its early detection is challenging. Genetic testing and liver pathology are sometimes necessary for the diagnosis of WD. This case underscores the consideration of WD in the differential diagnosis of patients with liver cirrhosis. Normal ceruloplasmin levels do not rule out WD.

Indexed as

CeruloplasminCopperDiabetes Mellitus, Type 2Hepatolenticular DegenerationAdultCopper-Transporting ATPasesFemaleHumansLiver CirrhosisPenicillamineATP7B protein, humanCeruloplasminCopperCopper-Transporting ATPasesPenicillaminecase reportceruloplasmingenetic metabolic diseaseMODYWilson disease

Identifiers

PMID40629618
PMCPMC12237300

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.